4
Changes in Ownership
Arbutus Biopharma Corp Filed Acc 0001140361-17-014873
Options or other derivatives
- Chief Development Officer acquired 50,000 shares (grant or award)
From the SEC's structured data for this filing
Arbutus Biopharma Corp Filed Acc 0001140361-17-014873
Options or other derivatives
From the SEC's structured data for this filing
Connection lost
Reconnecting…
Cite Filings isn't responding
Reconnecting…